Deutsche Märkte geschlossen

GSK plc (GSK.L)

LSE - LSE Verzögerter Preis. Währung in GBp (0.01 GBP)
Zur Watchlist hinzufügen
1.746,50+6,50 (+0,37%)
Börsenschluss: 05:15PM BST

GSK plc

980 Great West Road
Middlesex
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
https://www.gsk.com

Sektor(en)Healthcare
BrancheDrug Manufacturers - General
Vollzeitmitarbeiter70.212

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Ms. Emma Natasha WalmsleyCEO & Director5,39M53,92M1969
Ms. Julie Belita BrownCFO & Executive Director5,14MN/A1962
Ms. Shobie RamakrishnanChief Digital & Technology OfficerN/AN/A1971
Mr. Tony WoodChief Scientific Officer and Head of R&DN/AN/AN/A
Ms. Sarah Elton-FarrHead of Investor RelationsN/AN/AN/A
Mr. James FordSenior VP & Group General Counsel of Legal & ComplianceN/AN/AN/A
Ms. Sally JacksonSenior Vice President of Global Communications & CEO OfficeN/AN/AN/A
Mr. David Simon Redfern BSc (Hons), CAPresident of Corporate DevelopmentN/AN/A1966
Ms. Diana ConradChief People OfficerN/AN/AN/A
Mr. Philip C. ThomsonPresident of Global AffairsN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate Governance

GSK plcs ISS Governance QualityScore, Stand 1. Mai 2024, lautet 9. Die grundlegenden Scores sind Audit: 10, Vorstand: 5, Shareholderrechte: 1, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.